Katrien Princen
Rega Institute for Medical Research
Katholieke Universiteit Leuven
Department of Virology and Chemotherapy
Ninderbroedersstraat 10
Belgium
Name/email consistency: high
- HIV chemokine receptor inhibitors as novel anti-HIV drugs. Princen, K., Schols, D. Cytokine Growth Factor Rev. (2005)
- Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists. Princen, K., Hatse, S., Vermeire, K., De Clercq, E., Schols, D. Retrovirology (2004)
- Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry. Princen, K., Hatse, S., Vermeire, K., De Clercq, E., Schols, D. Cytometry. A (2003)
- The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level. Princen, K., Hatse, S., Vermeire, K., Bridger, G.J., Skerlj, R.T., De Clercq, E., Schols, D. AIDS Res. Hum. Retroviruses (2003)